TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Postoperative Nausea and Vomiting (PONV) Market Research Report 2023

Global Postoperative Nausea and Vomiting (PONV) Market Research Report 2023

  • Category:Life Sciences
  • Published on : 09 February 2023
  • Pages :89
  • Formats:
  • Report Code:SMR-7556564

Market Analysis and Insights: Global Postoperative Nausea Vomiting PONV Market

The global Postoperative Nausea Vomiting PONV market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Postoperative Nausea Vomiting PONV market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Postoperative Nausea Vomiting PONV market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Postoperative Nausea Vomiting PONV market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Postoperative Nausea Vomiting PONV market.

Global Postoperative Nausea Vomiting PONV Scope and Market Size

Postoperative Nausea and Vomiting (PONV) market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Postoperative Nausea and Vomiting (PONV) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2032.
Segment by Type
  • Serotonin Antagonists
  • Steroids
  • Dopamine Antagonists
  • NK-1 Receptor Antagonists
  • Non-pharmacologic Treatment
  • Others
Segment by Application
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
By Region
  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA
By Company
  • Acacia Pharma
  • F. Hoffmann-La Roche
  • Novartis
  • Ani Pharmaceuticals
  • Camurus
  • Sanofi
  • Helsinn Holding
  • Eisai
  • Merck
  • GlaxoSmithKline

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Postoperative Nausea Vomiting PONV product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Postoperative Nausea Vomiting PONV, with price, sales, revenue, and global market share of Postoperative Nausea Vomiting PONV from 2019 to 2022.

Chapter 3, the Postoperative Nausea Vomiting PONV competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Postoperative Nausea Vomiting PONV breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Postoperative Nausea Vomiting PONV market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Postoperative Nausea Vomiting PONV.

Chapter 13, 14, and 15, to describe Postoperative Nausea Vomiting PONV sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Postoperative Nausea Vomiting PONV Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

TABLE OF CONTENTS

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate by Type: 2018 VS 2022 VS 2032
1.2.2 Serotonin Antagonists
1.2.3 Steroids
1.2.4 Dopamine Antagonists
1.2.5 NK-1 Receptor Antagonists
1.2.6 Non-pharmacologic Treatment
1.2.7 Others
1.3 Market by Application
1.3.1 Global Postoperative Nausea and Vomiting (PONV) Market Share by Application: 2018 VS 2022 VS 2032
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Postoperative Nausea and Vomiting (PONV) Market Perspective (2018-2032)
2.2 Postoperative Nausea and Vomiting (PONV) Growth Trends by Region
2.2.1 Postoperative Nausea and Vomiting (PONV) Market Size by Region: 2018 VS 2022 VS 2032
2.2.2 Postoperative Nausea and Vomiting (PONV) Historic Market Size by Region (2018-2023)
2.2.3 Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Region (2023-2032)
2.3 Postoperative Nausea and Vomiting (PONV) Market Dynamics
2.3.1 Postoperative Nausea and Vomiting (PONV) Industry Trends
2.3.2 Postoperative Nausea and Vomiting (PONV) Market Drivers
2.3.3 Postoperative Nausea and Vomiting (PONV) Market Challenges
2.3.4 Postoperative Nausea and Vomiting (PONV) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Postoperative Nausea and Vomiting (PONV) Players by Revenue
3.1.1 Global Top Postoperative Nausea and Vomiting (PONV) Players by Revenue (2018-2023)
3.1.2 Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Players (2018-2023)
3.2 Global Postoperative Nausea and Vomiting (PONV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Postoperative Nausea and Vomiting (PONV) Revenue
3.4 Global Postoperative Nausea and Vomiting (PONV) Market Concentration Ratio
3.4.1 Global Postoperative Nausea and Vomiting (PONV) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Postoperative Nausea and Vomiting (PONV) Revenue in 2022
3.5 Postoperative Nausea and Vomiting (PONV) Key Players Head office and Area Served
3.6 Key Players Postoperative Nausea and Vomiting (PONV) Product Solution and Service
3.7 Date of Enter into Postoperative Nausea and Vomiting (PONV) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Postoperative Nausea and Vomiting (PONV) Breakdown Data by Type
4.1 Global Postoperative Nausea and Vomiting (PONV) Historic Market Size by Type (2018-2023)
4.2 Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Type (2023-2032)
5 Postoperative Nausea and Vomiting (PONV) Breakdown Data by Application
5.1 Global Postoperative Nausea and Vomiting (PONV) Historic Market Size by Application (2018-2023)
5.2 Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America Postoperative Nausea and Vomiting (PONV) Market Size (2018-2032)
6.2 North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2018-2023)
6.3 North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2023-2032)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Postoperative Nausea and Vomiting (PONV) Market Size (2018-2032)
7.2 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2018-2023)
7.3 Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2023-2032)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size (2018-2032)
8.2 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Country (2018-2023)
8.3 Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Country (2023-2032)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Postoperative Nausea and Vomiting (PONV) Market Size (2018-2032)
9.2 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2018-2023)
9.3 Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2023-2032)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size (2018-2032)
10.2 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2018-2023)
10.3 Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2023-2032)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Acacia Pharma
11.1.1 Acacia Pharma Company Detail
11.1.2 Acacia Pharma Business Overview
11.1.3 Acacia Pharma Postoperative Nausea and Vomiting (PONV) Introduction
11.1.4 Acacia Pharma Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
11.1.5 Acacia Pharma Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Detail
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Postoperative Nausea and Vomiting (PONV) Introduction
11.3.4 Novartis Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
11.3.5 Novartis Recent Development
11.4 Ani Pharmaceuticals
11.4.1 Ani Pharmaceuticals Company Detail
11.4.2 Ani Pharmaceuticals Business Overview
11.4.3 Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Introduction
11.4.4 Ani Pharmaceuticals Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
11.4.5 Ani Pharmaceuticals Recent Development
11.5 Camurus
11.5.1 Camurus Company Detail
11.5.2 Camurus Business Overview
11.5.3 Camurus Postoperative Nausea and Vomiting (PONV) Introduction
11.5.4 Camurus Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
11.5.5 Camurus Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Detail
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Postoperative Nausea and Vomiting (PONV) Introduction
11.6.4 Sanofi Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
11.6.5 Sanofi Recent Development
11.7 Helsinn Holding
11.7.1 Helsinn Holding Company Detail
11.7.2 Helsinn Holding Business Overview
11.7.3 Helsinn Holding Postoperative Nausea and Vomiting (PONV) Introduction
11.7.4 Helsinn Holding Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
11.7.5 Helsinn Holding Recent Development
11.8 Eisai
11.8.1 Eisai Company Detail
11.8.2 Eisai Business Overview
11.8.3 Eisai Postoperative Nausea and Vomiting (PONV) Introduction
11.8.4 Eisai Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
11.8.5 Eisai Recent Development
11.9 Merck
11.9.1 Merck Company Detail
11.9.2 Merck Business Overview
11.9.3 Merck Postoperative Nausea and Vomiting (PONV) Introduction
11.9.4 Merck Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
11.9.5 Merck Recent Development
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Detail
11.10.2 GlaxoSmithKline Business Overview
11.10.3 GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Introduction
11.10.4 GlaxoSmithKline Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
11.10.5 GlaxoSmithKline Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Postoperative Nausea and Vomiting (PONV) Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2032
Table 2. Key Players of Serotonin Antagonists
Table 3. Key Players of Steroids
Table 4. Key Players of Dopamine Antagonists
Table 5. Key Players of NK-1 Receptor Antagonists
Table 6. Key Players of Non-pharmacologic Treatment
Table 7. Key Players of Others
Table 8. Global Postoperative Nausea and Vomiting (PONV) Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2032
Table 9. Global Postoperative Nausea and Vomiting (PONV) Market Size by Region (US$ Million): 2018 VS 2022 VS 2032
Table 10. Global Postoperative Nausea and Vomiting (PONV) Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Postoperative Nausea and Vomiting (PONV) Market Share by Region (2018-2023)
Table 12. Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Region (2023-2032) & (US$ Million)
Table 13. Global Postoperative Nausea and Vomiting (PONV) Market Share by Region (2023-2032)
Table 14. Postoperative Nausea and Vomiting (PONV) Market Trends
Table 15. Postoperative Nausea and Vomiting (PONV) Market Drivers
Table 16. Postoperative Nausea and Vomiting (PONV) Market Challenges
Table 17. Postoperative Nausea and Vomiting (PONV) Market Restraints
Table 18. Global Postoperative Nausea and Vomiting (PONV) Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Postoperative Nausea and Vomiting (PONV) Market Share by Players (2018-2023)
Table 20. Global Top Postoperative Nausea and Vomiting (PONV) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Postoperative Nausea and Vomiting (PONV) as of 2022)
Table 21. Ranking of Global Top Postoperative Nausea and Vomiting (PONV) Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Postoperative Nausea and Vomiting (PONV) Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Postoperative Nausea and Vomiting (PONV) Product Solution and Service
Table 25. Date of Enter into Postoperative Nausea and Vomiting (PONV) Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Postoperative Nausea and Vomiting (PONV) Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Type (2018-2023)
Table 29. Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Type (2023-2032) & (US$ Million)
Table 30. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Type (2023-2032)
Table 31. Global Postoperative Nausea and Vomiting (PONV) Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Application (2018-2023)
Table 33. Global Postoperative Nausea and Vomiting (PONV) Forecasted Market Size by Application (2023-2032) & (US$ Million)
Table 34. Global Postoperative Nausea and Vomiting (PONV) Revenue Market Share by Application (2023-2032)
Table 35. North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2023-2032) & (US$ Million)
Table 37. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Postoperative Nausea and Vomiting (PONV) Market Size by Country (2023-2032) & (US$ Million)
Table 39. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size by Region (2023-2032) & (US$ Million)
Table 41. Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Postoperative Nausea and Vomiting (PONV) Market Size by Country (2023-2032) & (US$ Million)
Table 43. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size by Country (2023-2032) & (US$ Million)
Table 45. Acacia Pharma Company Detail
Table 46. Acacia Pharma Business Overview
Table 47. Acacia Pharma Postoperative Nausea and Vomiting (PONV) Product
Table 48. Acacia Pharma Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023) & (US$ Million)
Table 49. Acacia Pharma Recent Development
Table 50. F. Hoffmann-La Roche Company Detail
Table 51. F. Hoffmann-La Roche Business Overview
Table 52. F. Hoffmann-La Roche Postoperative Nausea and Vomiting (PONV) Product
Table 53. F. Hoffmann-La Roche Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023) & (US$ Million)
Table 54. F. Hoffmann-La Roche Recent Development
Table 55. Novartis Company Detail
Table 56. Novartis Business Overview
Table 57. Novartis Postoperative Nausea and Vomiting (PONV) Product
Table 58. Novartis Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023) & (US$ Million)
Table 59. Novartis Recent Development
Table 60. Ani Pharmaceuticals Company Detail
Table 61. Ani Pharmaceuticals Business Overview
Table 62. Ani Pharmaceuticals Postoperative Nausea and Vomiting (PONV) Product
Table 63. Ani Pharmaceuticals Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023) & (US$ Million)
Table 64. Ani Pharmaceuticals Recent Development
Table 65. Camurus Company Detail
Table 66. Camurus Business Overview
Table 67. Camurus Postoperative Nausea and Vomiting (PONV) Product
Table 68. Camurus Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023) & (US$ Million)
Table 69. Camurus Recent Development
Table 70. Sanofi Company Detail
Table 71. Sanofi Business Overview
Table 72. Sanofi Postoperative Nausea and Vomiting (PONV) Product
Table 73. Sanofi Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023) & (US$ Million)
Table 74. Sanofi Recent Development
Table 75. Helsinn Holding Company Detail
Table 76. Helsinn Holding Business Overview
Table 77. Helsinn Holding Postoperative Nausea and Vomiting (PONV) Product
Table 78. Helsinn Holding Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023) & (US$ Million)
Table 79. Helsinn Holding Recent Development
Table 80. Eisai Company Detail
Table 81. Eisai Business Overview
Table 82. Eisai Postoperative Nausea and Vomiting (PONV) Product
Table 83. Eisai Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023) & (US$ Million)
Table 84. Eisai Recent Development
Table 85. Merck Company Detail
Table 86. Merck Business Overview
Table 87. Merck Postoperative Nausea and Vomiting (PONV) Product
Table 88. Merck Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023) & (US$ Million)
Table 89. Merck Recent Development
Table 90. GlaxoSmithKline Company Detail
Table 91. GlaxoSmithKline Business Overview
Table 92. GlaxoSmithKline Postoperative Nausea and Vomiting (PONV) Product
Table 93. GlaxoSmithKline Revenue in Postoperative Nausea and Vomiting (PONV) Business (2018-2023) & (US$ Million)
Table 94. GlaxoSmithKline Recent Development
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Postoperative Nausea and Vomiting (PONV) Market Share by Type: 2022 VS 2032
Figure 2. Serotonin Antagonists Features
Figure 3. Steroids Features
Figure 4. Dopamine Antagonists Features
Figure 5. NK-1 Receptor Antagonists Features
Figure 6. Non-pharmacologic Treatment Features
Figure 7. Others Features
Figure 8. Global Postoperative Nausea and Vomiting (PONV) Market Share by Application in 2022 & 2032
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Postoperative Nausea and Vomiting (PONV) Report Years Considered
Figure 13. Global Postoperative Nausea and Vomiting (PONV) Market Size (US$ Million), Year-over-Year: 2018-2032
Figure 14. Global Postoperative Nausea and Vomiting (PONV) Market Size, (US$ Million), 2018 VS 2022 VS 2032
Figure 15. Global Postoperative Nausea and Vomiting (PONV) Market Share by Region: 2022 VS 2032
Figure 16. Global Postoperative Nausea and Vomiting (PONV) Market Share by Players in 2022
Figure 17. Global Top Postoperative Nausea and Vomiting (PONV) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Postoperative Nausea and Vomiting (PONV) as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Postoperative Nausea and Vomiting (PONV) Revenue in 2022
Figure 19. North America Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 20. North America Postoperative Nausea and Vomiting (PONV) Market Share by Country (2018-2032)
Figure 21. United States Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 22. Canada Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 23. Europe Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 24. Europe Postoperative Nausea and Vomiting (PONV) Market Share by Country (2018-2032)
Figure 25. Germany Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 26. France Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 27. U.K. Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 28. Italy Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 29. Russia Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 30. Nordic Countries Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 31. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 32. Asia-Pacific Postoperative Nausea and Vomiting (PONV) Market Share by Region (2018-2032)
Figure 33. China Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 34. Japan Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 35. South Korea Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 36. Southeast Asia Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 37. India Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 38. Australia Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 39. Latin America Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 40. Latin America Postoperative Nausea and Vomiting (PONV) Market Share by Country (2018-2032)
Figure 41. Mexico Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 42. Brazil Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 43. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 44. Middle East & Africa Postoperative Nausea and Vomiting (PONV) Market Share by Country (2018-2032)
Figure 45. Turkey Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 46. Saudi Arabia Postoperative Nausea and Vomiting (PONV) Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 47. Acacia Pharma Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
Figure 48. F. Hoffmann-La Roche Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
Figure 49. Novartis Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
Figure 50. Ani Pharmaceuticals Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
Figure 51. Camurus Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
Figure 52. Sanofi Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
Figure 53. Helsinn Holding Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
Figure 54. Eisai Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
Figure 55. Merck Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
Figure 56. GlaxoSmithKline Revenue Growth Rate in Postoperative Nausea and Vomiting (PONV) Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

Offer REPORT BUYING OPTIONS

USD GBP EURO YEN Single User Price
USD GBP EURO YEN Multi User Price
USD GBP EURO YEN Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount